BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Aidoud A, Marlet J, Angoulvant D, Debacq C, Gavazzi G, Fougère B. Influenza vaccination as a novel means of preventing coronary heart disease: Effectiveness in older adults. Vaccine 2020;38:4944-55. [PMID: 32536551 DOI: 10.1016/j.vaccine.2020.05.070] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Mezentsev A, Bezsonov E, Kashirskikh D, Baig MS, Eid AH, Orekhov A. Proatherogenic Sialidases and Desialylated Lipoproteins: 35 Years of Research and Current State from Bench to Bedside. Biomedicines 2021;9:600. [PMID: 34070542 DOI: 10.3390/biomedicines9060600] [Reference Citation Analysis]
2 Moholdt T, Afoakwah C, Scuffham P, McDonald CF, Burrell LM, Stewart S. Excess mortality at Christmas due to cardiovascular disease in the HUNT study prospective population-based cohort in Norway. BMC Public Health 2021;21:549. [PMID: 33743642 DOI: 10.1186/s12889-021-10503-7] [Reference Citation Analysis]
3 Macounová P, Maďar R. (What are the benefits of vaccination for the patients with cardiovascular diseases?). Cor Vasa 2021;63:86-9. [DOI: 10.33678/cor.2020.104] [Reference Citation Analysis]
4 Carrico J, Talbird SE, La EM, Poston S, Poirrier JE, DeMartino JK, Hogea C. Cost-benefit analysis of vaccination against four preventable diseases in older adults: Impact of an aging population. Vaccine 2021;39:5187-97. [PMID: 34334253 DOI: 10.1016/j.vaccine.2021.07.029] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Amato M, Werba JP, Frigerio B, Coggi D, Sansaro D, Ravani A, Ferrante P, Veglia F, Tremoli E, Baldassarre D. Relationship between Influenza Vaccination Coverage Rate and COVID-19 Outbreak: An Italian Ecological Study. Vaccines (Basel) 2020;8:E535. [PMID: 32947988 DOI: 10.3390/vaccines8030535] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 18.5] [Reference Citation Analysis]
6 García-Lledó A, Rodríguez-Martín S, Tobías A, García-de-Santiago E, Ordobás-Gavín M, Ansede-Cascudo JC, Alonso-Martín J, de Abajo FJ. Relationship Between Influenza, Temperature, and Type 1 Myocardial Infarction: An Ecological Time-Series Study. J Am Heart Assoc 2021;10:e019608. [PMID: 33829851 DOI: 10.1161/JAHA.120.019608] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
7 Moons P, Fieuws S, Vandermeulen C, Ombelet F, Willems R, Goossens E, Van Bulck L, de Hosson M, Annemans L, Budts W, De Backer J, Moniotte S, Marelli A, De Groote K; BELCODAC Consortium. Influenza Vaccination in Patients With Congenital Heart Disease in the Pre-COVID-19 Era: Coverage Rate, Patient Characteristics, and Outcomes. Can J Cardiol 2021:S0828-282X(21)00216-6. [PMID: 33961983 DOI: 10.1016/j.cjca.2021.04.010] [Reference Citation Analysis]
8 Redondo E, Rivero-Calle I, Mascarós E, Yuste JE, Fernández-Prada M, Ocaña D, Jimeno I, Gil A, Molina J, Díaz-Maroto JL, Linares M, Martinón-Torres F; en nombre de Neumoexpertos en Prevención. [Vaccination against community acquired pneumonia in adults. Update 2021 of the position paper by Neumoexpertos en Prevención Group]. Semergen 2021:S1138-3593(21)00180-5. [PMID: 34332864 DOI: 10.1016/j.semerg.2021.06.005] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]